SCHEMBL3722377

SCHEMBL3722377

COc1ccc(Oc2ccc([C@@H](C)NC(=O)C3(NC(=O)c4cncc(Cl)c4)CC3)nc2)c(C(F)(F)F)c1

nearest known ligand 0.43

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 7/20 0.43
BDKRB1 P46663 8/20 0.37
CACNA1I Q9P0X4 2/20 0.37
CACNA1G O43497 1/20 0.37
CACNA1H O95180 1/20 0.37
CNR2 P34972 1/20 0.37
KCNH2 Q12809 1/20 0.37
HPGDS O60760 1/20 0.36
S1PR3 Q99500 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3722299 0.93 CNR1 (0.46) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL3728225 0.92 CNR1 (0.42) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL3718996 0.92 CNR1 (0.44) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL3801380 0.92 CNR1 (0.42) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL13191282 0.91 CNR1 (0.43) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL13191405 0.91 BDKRB1 (0.45) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL13191728 0.87 BDKRB1 (0.45) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL3722459 0.85 BDKRB1 (0.38) CNR1BDKRB1CACNA1ICACNA1GCACNA1H
SCHEMBL3722271 0.85 BDKRB1 (0.43) CNR1BDKRB1HPGDS
SCHEMBL3722282 0.84 CACNA1I (0.38) CNR1BDKRB1CACNA1ICACNA1GCACNA1H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010097373-A1 COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed
WO-2010097373-A1 COMPOUNDS FOR USE AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed